Is part of the research team in Clinical Epidemiology at the Ottawa Hospital Research Institute.
Is also a physician with the Critical Care Team at The Ottawa Hospital and assistant professor at the Department of Medicine, University of Ottawa.
Her program of research is focused on examining fluid resuscitation practices in the critically ill and specifically, septic shock in Canadian Intensive Care Units.
She will lead the first clinical trial in the world of a stem cell therapy for septic shock. This deadly condition occurs when an infection spreads throughout the body and over-activates the immune system, resulting in severe organ damage and death in 30 to 40 per cent of cases. Under the leadership of Dr. Lauralyn McIntyre, this new “Phase I” trial will test the experimental therapy in up to 15 patients with septic shock at The Ottawa Hospital’s ICU.